Galvanize Therapeutics, Inc.
StreetZero Signal 83
About Galvanize Therapeutics, Inc.
Galvanize Therapeutics, Inc. is a commercial-stage medical technology company pioneering pulsed electric field (PEF) ablation technologies for oncology and chronic disease. It develops non-thermal, non-pharmacologic interventions using short electrical pulses to target pathologic cells, including the Aliya® PEF platform for solid tumors and RheOx® therapy for chronic bronchitis. The company aims to become a global leader in medical technology innovations that drive biologic processes to treat a range of diseases.
LATEST FUNDINGPrivate Placement
$136.2M
Announced 2026-11-18
TOTAL RAISED$291.01M
IN THE NEWS
- 🔗 Galvanize Therapeutics Valuation, Funding & Investors | Multiples
- 🔗 Galvanize Therapeutics raises $100 million in Oversubscribed Series C Financing to Transform the Treatment of Cancer and Chronic Lung Disease
- 🔗 Galvanize Therapeutics Raises $130 Million in Oversubscribed Series D Financing to Accelerate Commercial Growth and Advance PEF Innovation | Newswise
- 🔗 Galvanize Therapeutics Merges 3 Companies, Nabs $100M
- 🔗 Galvanize Electrophysiology Company Overview, Contact Details & Competitors | LeadIQ
EMPLOYEES—
FOUNDED2015
HQRedwood City, CA, United States
Industry
Biotechnology
Tags
BiotechnologyMedical TechnologyPEF AblationOncology
Investors
Key highlights
- Raised $100M oversubscribed Series C in 2025 led by Sofinnova Partners to expand commercial footprint and advance Aliya PEF and RheOx therapies.
- Closed $130M oversubscribed Series D in 2026 led by HealthQuest Capital to accelerate commercial growth.
- Platform uses non-thermal short-duration electrical pulses to destabilize cellular pathologic processes.
- Total funding exceeds $291M with backing from Fidelity, Apple Tree Partners and others.
Ask StreetZero about Galvanize Therapeutics, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account